The health effects of exposure to arsenic-contaminated drinking water: A review by global geographical distribution

International Journal of Environmental Health Research

Volumn 25, Issue 4, 2015, Pages 432-452

  Huang, Lei ^a   Wu, Haiyun ^a   Van Der Kuijp, Tsering Jan ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

arsenic; drinking water; epidemiology; health

Indexed keywords

ARSENIC; DRINKING WATER; WATER POLLUTANT;

ARSENIC; CANCER; DRINKING WATER; EPIDEMIOLOGY; GEOGRAPHICAL DISTRIBUTION; HEALTH IMPACT; HEALTH RISK; LITERATURE REVIEW; POLLUTION EXPOSURE; PUBLIC HEALTH;

ARGENTINA; ARSENIC POISONING; BANGLADESH; CHILE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PLANNING; EUROPE; GENDER; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; INDIA; IRAN; JAPAN; KOREA; LONG TERM EXPOSURE; MEXICO; REVIEW; SKIN CANCER; TAIWAN; UNITED STATES; WATER CONTAMINATION; CHEMICALLY INDUCED; NEOPLASMS; TOXICITY; WATER POLLUTANT;

TAIWAN;

ARSENIC; ARSENIC POISONING; DRINKING WATER; HUMANS; NEOPLASMS; WATER POLLUTANTS, CHEMICAL;

EID: 84931567863     PISSN: 09603123     EISSN: 13691619     Source Type: Journal    
DOI: 10.1080/09603123.2014.958139     Document Type: Review

References (154)

1. Abhyankar LN, Jones MR, Guallar E, Navas-Acien A. 2012. Arsenic exposure and hypertension: a systematic review. Environ Health Perspect. 120:494-500.
2. Ahmad SA, Sayed M, Barua S, Khan MH, Faruquee M, Jalil A, Hadi SA, Talukder HK. 2001. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect. 109:629-631.
3. Ahsan H, Chen Y, Parvez F, Argos M, Hussain AI, Momotaj H, Levy D, van Geen A, Howe Geoffrey, Graziano J. 2006. Health Effects of Arsenic Longitudinal Study (HEALS): description of a multidisciplinary epidemiologic investigation. J Expo Sci Environ Epidemiol. 16:191-205.
4. Argos M, Ahsan H, Graziano JH. 2012. Arsenic and human health: epidemiologic progress and public health implications. Rev Environ Health. 27:191-195.
5. Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, et al. 2010. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. The Lancet. 376:252-258.
6. Börzsönyi M, Bereczky A, Rudnai P, Csanady M, Horvath A. 1992. Epidemiological studies on human subjects exposed to arsenic in drinking water in Southeast Hungary. Arch Toxicol. 66:77-78.
7. Baastrup R, Sørensen M, Balstrøm T, Frederiksen K, Larsen CL, Tjønneland A, Overvad K, Raaschou-Nielsen O. 2008. Arsenic in drinking-water and risk for cancer in Denmark. Environ Health Perspect. 116:231-237.
8. Bates MN, Rey OA, Biggs ML, Hopenhayn C, Moore LE, Kalman D, Steinmaus C, Smith AH. 2004. Case-control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiol. 159:381-389.
9. Bates MN, Smith AH, Cantor KP. 1995. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol. 15:523-530. Epub 1995/03/15.
10. Buchet J, Lison D. 1998. Mortality by cancer in groups of the Belgian population with a moderately increased intake of arsenic. Int Arch Occup Environ Health. 71:125-130.
11. Bundschuh J, Litter MI, Parvez F, Román-Ross G, Nicolli HB, Jean JS, Liu CW, López D, Armienta MA, Guilherme LRG, et al. 2012. One century of arsenic exposure in Latin America: a review of history and occurrence from 14 countries. Sci Total Environ. 429:2-35.
12. Calderon RL, Hudgens EE, Carty C, He B, Le XC, Rogers J, Thomas DJ. 2013. Biological and behavioral factors modify biomarkers of arsenic exposure in a US population. Environ Res. 126:134-144.
13. Celik I, Gallicchio L, Boyd K, Lam TK, Matanoski G, Tao X, Shiels M, Hammond E, Chen L, Robinson KA. 2008. Arsenic in drinking water and lung cancer: a systematic review. Environ Res. 108:48-55.
14. Chen CJ, Chen CW, Wu MM, Kuo T-L. 1992. Cancer potential in liver lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 66:888-892.
15. Chen CJ, Chuang Y, You S, Lin T, Wu H. 1986. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer. 53:399-405.
16. Chen CJ, Chuang YC, Lin TM, Wu HY. 1985. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-Arsenic artesian well water and cancers. Cancer Res. 45:5895-5899.
17. Chen CJ, Tsung LK, Wu MM. 1988. Arsenic and cancers. The Lancet. 331:414-415.
18. Chen CJ, Wang CJ. 1990. Ecological correlation between arsenic level in well water and ageadjusted mortality from malignant neoplasms. Cancer Res. 50:5470-5474. Epub 1990/09/01.
19. Chen CJ, Wang SL, Chiou JM, Tseng CH, Chiou HY, Hsueh YM, Chen SY, Wu MM, Lai MS. 2007. Arsenic and diabetes and hypertension in human populations: a review. Toxicol Appl Pharmacol. 222:298-304.
20. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu H-Y. 1988. Atherogenicity and carcinogenicity of high-Arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arterioscler Thromb Vasc Biol. 8:452-460.
21. Chen CL, Chiou HY, Hsu Li, Hsueh YM, Wu MM, Chen CJ. 2010. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan. Environ Res. 110:455-462.
22. Chen CL, Chiou HY, Hsu Li, Hsueh YM, Wu MM, Wang YH, Chen CJ. 2010. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from Northeastern Taiwan. Cancer Epidemiol Biomarkers Prev. 19:101-110.
23. Chen CL, Hsu Li, Chiou HY, Hsueh YM, Chen SY, Wu MM, Chen CJ, Blackfoot Dis Study G. 2004. Ingested arsenic, cigarette smoking, and lung cancer risk: a follow-up study in arseniasis-endemic areas in Taiwan. J Am Med Assoc. 292:2984-2990.
24. Chen S-C, Chen C-C, Kuo C-Y, Huang C-H, Lin C-H, Lu Z-Y, Chen Y-Y, Lee H-S, Wong R-H. 2012. Elevated risk of hypertension induced by arsenic exposure in Taiwanese rural residents: possible effects of manganese superoxide dismutase (MnSOD) and 8-oxoguanine DNA glycosylase (OGG1) genes. Arch Toxicol. 86:869-878.
25. Chen Y, Ahsan H, Slavkovich V, Peltier GL, Gluskin RT, Parvez F, Liu XH, Graziano JH. 2010. No association between arsenic exposure from drinking water and diabetes mellitus: a crosssectional study in Bangladesh. Environ Health Perspect. 118:1299-1305.
26. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, Parvez F, van Geen A, Ahsan H. 2007. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am J Epidemiol. 165:541-552.
27. Chen Y, Graziano JH, Parvez F, Liu M, Slavkovich V, Kalra T, Argos M, Islam T, Ahmed A, Rakibuz-Zaman M, et al. 2011. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. Br Med J. 342:d2431. Epub 2011/05/07.
28. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei M-L, Chen C-J. 2001. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in Northeastern Taiwan. Am J Epidemiol. 153:411-418.
29. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, Lin JS, Huang CH, Chen CJ. 1995. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 15:1296-1300. Epub 1995/03/15.
30. Chiu HF, Chang CC, Tsai SS, Yang CY. 2006. Does arsenic exposure increase the risk for diabetes mellitus? J Occup Environ Med. 48:63-67.
31. Chiu HF, Ho SC, Wang LY, Wu TN, Yang CY. 2004. Does arsenic exposure increase the risk for liver cancer? J Toxicol Environ Health A. 67:1491-1500.
32. Chiu HF, Ho SC, Yang CY. 2004. Lung cancer mortality reduction after installation of tap-water supply system in an arseniasis-endemic area in Southwestern Taiwan. Lung Cancer. 46:265-270.
33. Chiu HF, Yang CY. 2005. Decreasing trend in renal disease mortality after cessation from arsenic exposure in a previous arseniasis-endemic area in Southwestern Taiwan. J Toxicol Environ Health A. 68:319-327.
34. Christoforidou EP, Riza E, Kales SN, Hadjistavrou K, Stoltidi M, Kastania AN, Linos A. 2013. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence. J Environ Sci Health A. 48:1764-1775.
35. Chung CJ, Huang YL, Huang YK, Wu MM, Chen S-Y, Hsueh Y-M, Chen C-J. 2013a. Urinary arsenic profiles and the risks of cancer mortality: a population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan. Environ Res. 122:25-30.
36. Chung YL, Liaw YP, Hwang BF, Cheng Y-Y, Lin M-S, Kuo Y-C, Guo H-R. 2013b. Arsenic in drinking and lung cancer mortality in Taiwan. J Asian Earth Sci. 77:327-331.
37. Coronadogonzalez JA, Delrazo LM, Garciavargas G, Sanmiguelsalazar F, Escobedodelapena J. 2007. Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ Res. 104:383-389.
38. National Research Council. 2001. Arsenic in drinking water 2001. Update ed. Washington, DC: The National Academies Press.
39. Dauphiné DC, Smith AH, Yuan Y, Balmes JR, Bates MN, Steinmaus C. 2013. Case-control study of arsenic in drinking water and lung cancer in California and Nevada. Int J Environ Res Public Health. 10:3310-3324.
40. de Esparza MC. 2009. The presence of arsenic in drinking water in Latin America and its effect on public health. In Bundschuh J, Armienta MA, Birke P. Natural arsenic in groundwater of Latin America. Leiden AK: CRC Press; p. 17-29.
41. Del Razo LM, Garcia-Vargas GG, Valenzuela OL, Castellanos EH, Sanchez-Pena LC, Currier JM, Drobna Z, Loomis D, Styblo M. 2011. Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapan and Lagunera regions in Mexico. Environ Res. 10:73-84.
42. Dragana J, Zorica R-M, Katarina P, Branko J, Snezana P, Jelena M. 2013. Low levels of arsenic in drinking water and type 2 diabetes in Middle Banat region, Serbia. Int J Hyg Environ Health. 216:50-55.
43. Drobná Z, Del Razo LM, García-Vargas GG, Sánchez-Peña LC, Barrera-Hernández A, Stýblo M, Loomis D. 2013. Environmental exposure to arsenic, AS3MT polymorphism and prevalence of diabetes in Mexico. J Expo Sci Environ Epidemiol. 23:151-155.
44. Elizabeth A, Habibul A, Joshua E, Matthew PL, Navas-Acien A, Jingbo P, Ellen KS, Styblo M, Tseng C-H, Thayer KA, et al. 2012. Evalution of the association between arsenic and diabetes: a national toxicology program workshop review. Environ Health Perspect. 120:1658-1670.
45. Ferreccio C, Sancha AM. 2011. Arsenic exposure and its impact on health in Chile. J Health Popul Nutr. 24:164-175.
46. Ferreccio C, Smith AH, Duran V, Barlaro T, Benitez H, Valdes R, Aguirre JJ, Moore LE, Acevedo J, Vasquez MI. 2013. Case-control study of arsenic in drinking water and kidney cancer in uniquely exposed Northern Chile. Am J Epidemiol. 178:813-818.
47. García-Esquinas E, Pollan M, Umans J, Francesconi K, Goessler W, Guallar E, Howard B, Farley J, Yeh J, Best L. 2013. Arsenic exposure and cancer mortality in a US-based prospective cohort: the strong heart study. Cancer Epidemiol Biomarkers Prev. 22:1-10.
48. George CM, van Geen A, Slavkovich V, Singha A, Levy D, Islam T, Ahmed KM, Moon-Howard J, Tarozzi A, Liu X. 2012. A cluster-based randomized controlled trial promoting community participation in arsenic mitigation efforts in Bangladesh. Environ Health. 11:41.
49. Ghosh P, Banerjee M, De Chaudhuri S, Chowdhury R, Das JK, Mukherjee A, Sarkar AK, Mondal L, Baidya K, Sau TJ, et al. 2006. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water in West Bengal. India J Expos Sci Environ Epidemiol. 17:215-223. [Online]. [cited 2012 Jul].
50. Gilbert-Diamond D, Li Z, Perry AE, Spencer SK, Gandolfi AJ, Karagas MR. 2013. A populationbased case-control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Environ Health Perspect. 121:1154-1160.
51. Gloster HM Jr., Neal K. 2006. Skin cancer in skin of color. J Am Acad Dermatol. 55:741-760.
52. Gribble MO, Howard BV, Umans JG, Shara NM, Francesconi KA, Goessler W, Crainiceanu CM, Silbergeld EK, Guallar E, Navas-Acien A. 2012. Arsenic exposure, diabetes prevalence, and diabetes control in the strong heart study. Am J Epidemiol. 176:865-874.
53. Guo HR. 2004. Arsenic level in drinking water and mortality of lung cancer (Taiwan). Cancer Causes Control. 15:171-177.
54. Guo XJ, Hu L, Yand PZ, Tanabe K, Miyatalre M, Chen Y. 2007. Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects. J Environ Sci Health A Tox Hazard Subst Environ Eng. 42:1853-1858.
55. Guo XJ, Liu ZY, Huang CP, You LG. 2006. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia. J Health Popul Nutr. 24:214-220.
56. Han Y-Y, Weissfeld J, Davis D, Talbott E. 2009. Arsenic levels in ground water and cancer incidence in Idaho: an ecologic study. Int Arch Occup Environ Health. 82:843-849.
57. Hansen L, Whitehead JA, Anderson S. 2002. Solar UV radiation enhances the toxicity of arsenic in Ceriodaphnia dubia. Ecotoxicology. 11:279-287.
58. Haque R, Mazumder DNG, Samanta S, Ghosh N, Kalman D, Smith MM, Mitra S, Santra A, Lahiri S, Das S, et al. 2003. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology. 14:174-182.
59. Heck JE, Andrew AS, Onega T, Rigas JR, Jackson BP, Karagas MR, Duell EJ. 2009. Lung cancer in a US population with low to moderate arsenic exposure. Environ Health Perspect. 117:1718-1723.
60. Heck JE, Gamble MV, Chen Y, Graziano JH, Slavkovich V, Parvez F, Baron JA, Howe GR, Ahsan H. 2007. Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh. Am J Clin Nutr. 85:1367-1374.
61. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, Smith AH. 1996. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 7:117-124.
62. Hopenhayn-Rich C, Biggs ML, Smith AH. 1998. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol. 27:561-569.
63. Hsu L-I, Wang Y-H, Chiou H-Y, Wu M-M, Yang T-Y, Chen Y-H, Tseng C-H, Chen C-J. 2013. The association of diabetes mellitus with subsequent internal cancers in the arsenic-exposed area of Taiwan. J Asian Earth Sci. 73:452-459.
64. Huang YK, Tseng CH, Huang YL, Yang MH, Chen CJ, Hsueh YM. 2007. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol Appl Pharmacol. 218:135-142.
65. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2004. Some drinkingwater disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum. 84:1-477.
66. Islam MR, Khan I, Attia J, Hassan SM, McEvoy M, D'Este C, Azim S, Akhter A, Akter S, Shahidullah SM, et al. 2012. Association between hypertension and chronic arsenic exposure in drinking water: a cross-sectional study in Bangladesh. Int J Environ Res Public Health. 9:4522-4536. Epub 2012/12/12.
67. Islam MR, Khan I, Hassan SMN, McEvoy M, D'Este C, Attia J, Peel R, Sultana M, Akter S, Milton AH. 2012. Association between type 2 diabetes and chronic arsenic exposure in drinking water: a cross sectional study in Bangladesh. Environ Health. 11:38. Available from: http://www.ehjournal.net/content/11/1/38
68. James KA, Marshall JA, Hokanson JE, Meliker JR, Zerbe GO, Byers TE. 2013. A case-cohort study examining lifetime exposure to inorganic arsenic in drinking water and diabetes mellitus. Environ Res. 123:33-38.
69. Jones MR, Tellez-Plaza M, Sharrett AR, Guallar E, Navas-Acien A. 2011. Urine arsenic and hypertension in US adults the 2003-2008 national health and nutrition examination survey. Epidemiology. 22:153-161.
70. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, Greenberg ER. 2001. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based casecontrol study. Am J Epidemiol. 153:559-565. Epub 2001/03/21.
71. Karagas MR, Stukel TA, Tosteson TD. 2002. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int J Hyg Environ Health. 205:85-94.
72. Karagas MR, Tosteson T, Morris JS, Demidenko E, Mott L, Heaney J, Schned A. 2004. Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control. 15:465-472. 2004/06/01.
73. Kim NH, Mason CC, Nelson RG, Afton SE, Essader AS, Medlin JE, Levine KE, Hoppin JA, Lin C, Knowler WC, et al. 2013. Arsenic exposure and incidence of type 2 diabetes in Southwestern American Indians. Am J Epidemiol. 177:962-969. Epub 2013/03/19.
74. Knobeloch L, Zierold K, Anderson H. 2006. Association of arsenic-contaminated drinking-water with prevalence of skin cancer in Wisconsin's Fox River Valley. J Health Popul Nutr. 24:206-213.
75. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. 1999. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect. 107: 705-710. Epub 1999/08/28.
76. Kwok RK, Mendola P, Liu ZY, Savitz DA, Heiss G, Ling HL, Xia Y, Lobdell D, Zeng D, Thorp JM, et al. 2007. Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol Appl Pharmacol. 222:337-343.
77. Lamm SH, Engel A, Kruse MB, Feinleib M, Byrd DM, Lai S, Wilson R. 2004. Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 US counties and 30 years of observation. J Occup Environ Med. 46:298-306.
78. Lamm SH, Luo ZD, Bo FB, Zhang GY, Zhang YM, Wilson R, Byrd DM, Lai SH, Li FX, Polkanov M, et al. 2007. An epidemiologic study of arsenic-related skin disorders and skin cancer and the consumption of arsenic-contaminated well waters in Huhhot, Inner Mongolia, China. Hum Ecol Risk Assess. 13:713-746.
79. Lee B-K, Kim Y. 2013. Association of diabetes mellitus with a combination of vitamin D deficiency and arsenic exposure in the Korean general population: analysis of 2008-2009 Korean national health and nutrition examination survey data. Ann Occup Environ Med. 25:7.
80. Leonardi G, Vahter M, Clemens F, Goessler W, Gurzau E, Hemminki K, Hough R, Koppova K, Kumar R, Rudnai P, et al. 2012. inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ Health Perspect. 120:721-726.
81. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL. 1999. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect. 107:359-365. Epub 1999/04/22.
82. Li X, Li B, Xi S, Zheng Q, Lv X, Sun G. 2013. Prolonged environmental exposure of arsenic through drinking water on the risk of hypertension and type 2 diabetes. Environ Sci Pollut Res. 20:8151-8161.
83. Liu-Mares W, MacKinnon JA, Sherman R, Fleming LE, Rocha-Lima C, Hu JJ, Lee DJ. 2013. Pancreatic cancer clusters and arsenic-contaminated drinking water wells in Florida. BMC Cancer. 13:111. Available from: http://link.springer.com/article/10.1186%2F1471-2407-13-111
84. Mahram M, Shahsavari D, Oveisi S, Jalilolghadr S. 2013. Comparison of hypertension and diabetes mellitus prevalence in areas with and without water arsenic contamination. J Res Med Sci. 18:408-412.
85. Makris KC, Christophi CA, Paisi M, Ettinger AS. 2012. A preliminary assessment of low level arsenic exposure and diabetes mellitus in Cyprus. BMC Public Health. 12:334. Available from: http://www.biomedcentral.com/1471-2458/12/334
86. Malik AH, Khan ZM, Mahmood Q, Nasreen S, Bhatti ZA. 2009. Perspectives of low cost arsenic remediation of drinking water in Pakistan and other countries. J Hazard Mater. 168:1-12.
87. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, Selvin S, Liaw J, Smith AH. 2007. Fifty-year study of lung and bladder cancer mortality in chile related to arsenic in drinking water. J Natl Cancer Inst. 99:920-928.
88. Mazumder DNG, Haque R, Ghosh N, De BK, Santra A, Chakraborti D, Smith AH. 2000. Arsenic in drinking water and the prevalence of respiratory effects in West Bengal, India. Int J Epidemiol. 29:1047-1052.
89. Mazumder DNG, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, Smith AH. 1998. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol. 27:871-877.
90. Mazumder DNG, Kunal KM, Ishani K-P, Ghose Aloke, Mistry Goutam, Saha Chandan, Nandy A, Das A. 2013. Ischemic heart disease in chronic arsenic exposure: a case control study in West Bengal. Global Adv Res J. 2:047-054.
91. Mazumder DNG, Purkayastha I, Ghose A, Mistry G, Saha C, Nandy AK, Das A, Majumdar KK. 2012. Hypertension in chronic arsenic exposure: a case control study in West Bengal. J Environ Sci Health A. 47:1514-1520.
92. Mazumder DNG, Steinmaus C, Bhattacharya P, von Ehrenstein OS, Ghosh N, Gotway M, Sil A, Balmes JR, Haque R, Hira-Smith MM, et al. 2005. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology. 16:760-765.
93. Medrano MJ, Boix R, Pastor-Barriuso R, Palau M, Damián J, Ramis R, del Barrio JL, Navas-Acien A. 2010. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ Res. 110:448-454.
94. Meliker J, Slotnick M, AvRuskin G, Schottenfeld D, Jacquez G, Wilson M, Goovaerts P, Franzblau A, Nriagu J. 2010. Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA. Cancer Causes Control. 21:745-757.
95. Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D. 2004. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers. Am J Epidemiol. 160:853-859.
96. Moon K, Guallar E, Navas-Acien A. 2012. Arsenic exposure and cardiovascular disease:an updated systematic review. Curr Atheroscler Rep. 14:542-555.
97. Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ. 2000. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect. 108:655-661. Epub 2000/07/21.
98. Nakadaira H, Endoh K, Katagiri M, Yamamoto M. 2002. Elevated mortality from lung cancer associated with arsenic exposure for a limited duration. J Occup Environ Med. 44:291-299.
99. Navas-Acien A, Silbergeld EK, Roberto PB, Guallar E. 2009. Arsenic exposure and prevalence of type 2 diabetes: updated findings from the national health nutrition and examination survey, 2003-2006. Epidemiology. 20:816-820.
100. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Guallar E. 2005. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol. 162:1037-1049.
101. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. 2008. Arsenic exposure and prevalence of type 2 diabetes in US adults. J Am Med Assoc. 300:814-822.
102. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. 2006. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environ Health Perspect. 114:641-648.
103. Ng JC, Wang J, Shraim A. 2003. A global health problem caused by arsenic from natural sources. Chemosphere. 52:1353-1359.
104. Nordstrom DK. 2002. Worldwide occurrences of arsenic in ground water. Science. 296:2143-2145.
105. Orloff K, Mistry K, Metcalf S. 2009. Biomonitoring for environmental exposures to arsenic. J Toxicol Environ Health, Part B. 12:509-524.
106. Pan W-C, Hoffman E, Kile M, Seow WJ, Rahman M, Quamruzzaman Q, Mostofa G, Christiani D. 2012. A prospective follow-up study of arsenic exposure and type 2 diabetes in Bangladesh. Epidemiology. 23. Available from: http://journals.lww.com/epidem/Citation/2012/09001/E-009-A-Prospective-Follow-Up-Study-of-Arsenic.10.aspx
107. Parvez F, Chen Y, Brandt-Rauf PW, Slavkovich V, Islam T, Ahmed A, Argos M, Hassan R, Yunus M, Haque SE, et al. 2010. A prospective study of respiratory symptoms associated with chronic arsenic exposure in Bangladesh: findings from the Health Effects of Arsenic Longitudinal Study (HEALS). Thorax. 65:528-533.
108. Pierce BL, Kibriya MG, Tong L, Jasmine F, Argos M, Roy S, Paul-Brutus R, Rahaman R, Rakibuz-Zaman M, Parvez F. 2012. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet. 8:e1002522.
109. Ping TW. 1989. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology. 40:547-558.
110. Putila JJ, Guo NL. 2011. Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS ONE. 6:e25886.
111. Rahman M, Sohel N, Yunus M, Chowdhury ME, Hore SK, Zaman K, Bhuiya A, Streatfield PK. 2013. Increased childhood mortality and arsenic in drinking water in Matlab, Bangladesh: a population-based cohort study. PLoS ONE. 8:e55014.
112. Rahman M, Tondel M, Ahmad SA, Axelson O. 1998. Diabetes mellitus associated with arsenic exposure in Bangladesh. Am J Epidemiol. 148:198-203.
113. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. 1999. Hypertension and arsenic exposure in Bangladesh. Hypertension. 33:74-78. Epub 1999/02/04.
114. Rhee SY, Hwang Y-C, Woo Jeong-taek, Chin SO, Chon S, Kim YS. 2013. Arsenic exposure and prevalence of diabetes mellitus in Korean adults. J Korean Med Sci. 28:861-868.
115. Rodríguez-Lado L, Sun G, Berg M, Zhang Q, Xue H, Zheng Q, Johnson CA. 2013. Groundwater arsenic contamination throughout China. Science. 341:866-868.
116. Smith AH, Goycolea M, Haque R, Biggs ML. 1998. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol. 147:660-669.
117. Smith AH, Lingas EO, Rahman M. 2000. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 78:1093-1103.
118. Smith AH, Marshall G, Liaw J, Yuan Y, Ferreccio C, Steinmaus C. 2012. Mortality in young adults following in utero and childhood exposure to arsenic in drinking water. Environ Health Perspect. 120:1527-1531.
119. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, Steinmaus C, Bates MN, Selvin S. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect. 114:1293-1296.
120. Smith AH, Marshall G, Yuan Y, Liaw J, Ferreccio C, Steinmaus C. 2011. Evidence from chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Am J Epidemiol. 173:414-420.
121. Smith AH, Smith MMH. 2004. Arsenic drinking water regulations in developing countries with extensive exposure. Toxicology. 198:39-44.
122. Sohel N, Persson LA, Rahman M, Streatfield PK, Yunus M, Ekström E-C, Vahter M. 2009. Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology. 20:824-830.
123. Steinmaus C, Moore LE, Shipp M, Kalman D, Rey OA, Biggs ML, Hopenhayn C, Bates MN, Zheng S, Wiencke JK. 2007. Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J Toxicol Environ Health A. 70:159-170.
124. Steinmaus C, Yuan Y, Bates MN, Smith AH. 2003. Case-control study of bladder cancer and drinking water arsenic in the Western United States. Am J Epidemiol. 158:1193-1201. Epub 2003/12/04.
125. Steinmaus C, Yuan Y, Liaw J, Smith AH. 2009. Low-level population exposure to inorganic arsenic in the united states and diabetes mellitus: a reanalysis. Epidemiology. 20:807-815.
126. Steinmaus CM, Ferreccio C, Romo JA, Yuan Y, Cortes S, Marshall G, Moore LE, Balmes JR, Liaw J, Golden T, et al. 2013. Drinking water arsenic in Northern Chile: high cancer risks 40 years after exposure cessation. Cancer Epidemiol Biomarkers Prev. 22:623-630. Epub 2013/01/29.
127. Su CC, Lu JL, Tsai KY, Lian I-B. 2011. Reduction in arsenic intake from water has different impacts on lung cancer and bladder cancer in an arseniasis endemic area in Taiwan. Cancer Causes Control. 22:101-108.
128. Tsai SM, Wang TN, Ko YC. 1999. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health. 54:186-193.
129. Tsai SY, Chou HY, The HW, Chen CM, Chen CJ. 2003. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology. 24:747-753.
130. Tseng WP. 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 19:109-119.
131. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst. 40:453-463.
132. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, Kishi Y, Aoyama H. 1995. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol. 141:198-209.
133. Valberg PA, Beck BD, Boardman PD, Cohen JT. 1998. Likelihood ratio analysis of skin cancer prevalence associated with arsenic in drinking water in the USA. Environ Geochem Health. 20:61-66.
134. van der Kuijp TJ, Huang L, Cherry CR. 2013. Health hazards of China's lead-Acid battery industry: a review of its market drivers, production processes, and health impacts. Environ Health. 12:61. Available from: http://www.ehjournal.net/content/12/1/61
135. van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, Hussain I, Ahmed KM, Gelman A, Stute M, Simpson HJ, et al. 2002. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull World Health Organ. 80:732-737.
136. von Ehrenstein OS, Mazumder DNG, Yuan Y, Samanta S, Balmes J, Sil A, Ghosh N, Hira-Smith M, Haque R, Purushothamam R, et al. 2005. Decrements in lung function related to arsenic in drinking water in West Bengal, India. Am J Epidemiol. 162:533-541.
137. Wang CH, Hsiao CK, Chen CL, Hsu Li, Chiou HY, Chen SY, Hsueh YM, Wu MM, Chen CJ. 2007. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol. 222:315-326.
138. Wasserman GA, Liu XH, Parvez F, Ahsan H, Factor-Litvak P, van Geen A, Slavkovich V, Lolacono NJ, Cheng ZQ, Hussain L, et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 112:1329-1333.
139. Wasserman GA, Liu XH, Parvez F, Ahsan H, Factor-Litvak P, Kline J, van Geen A, Slavkovich V, Lolacono NJ, Levy D, et al. 2007. Water arsenic exposure and intellectual function in 6-year-old children in Araihazar, Bangladesh. Environ Health Perspect. 115:285-289.
140. WHO. 2012. Exposure to arsenic: a major public health concern. Available from http://www.who. int/ipcs/features/arsenic.pdf
141. WHO. 2010. Arsenic. Available from http://www.who.int/mediacentre/factsheets/fs372/en/
142. Wu MM, Kuo TL, Hwang YH, Chen CJ. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol. 130:1123-1132. Epub 1989/12/01.
143. Xia YJ, Wade TJ, Wu KG, Li YH, Ning ZX, Le XC, Chen Binfei, Feng Yong, Mumford Judy L., He Xingzhou. 2009. Well water arsenic exposure, arsenic induced skin-lesions and selfreported morbidity in Inner Mongolia. Int J Environ Res Public Health. 6:1010-1025.
144. Yang CY. 2006. Does arsenic exposure increase the risk of development of peripheral vascular diseases in humans? J Toxicol Environ Health A. 69:1797-1804.
145. Yang CY, Chang CC, Chiu HF. 2008. Does arsenic exposure increase the risk for prostate cancer? J Toxicol Environ Health A. 71:1559-1563.
146. Yang CY, Chang CC, Ho SC, Chiu HF. 2008. Is colon cancer mortality related to arsenic exposure J Toxicol Environ Health A. 71:533-538.
147. Yang TY, Hsu LI, Chen HC, Chiou HY, Hsueh YM, Wu MM, Chen CL, Wang YH, Liao YT, Chen CJ. 2013. Lifetime risk of urothelial carcinoma and lung cancer in the arseniasis-endemic area of Northeastern Taiwan. J Asian Earth Sci. 77:332-337.
148. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. 2005. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 14:243-250.
149. Yang LS, Peterson PJ, Williams WP, Wang WY, Hou SF, Tan JA. 2002. The relationship between exposure to arsenic concentrations in drinking water and the development of skin lesions in farmers from Inner Mongolia, China. Environ Geochem Health. 24:293-303.
150. Yildiz A, Karaca M, Biceroglu S, Nalbantcilar MT, Coskun U, Arik F, Aliyev F, Yiginer O, Turkoglu C. 2008. Effect of chronic arsenic exposure from drinking waters on the QT interval and transmural dispersion of repolarization. J Int Med Res. 36:471-478. Epub 2008/06/07.
151. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M, Smith AH. 2010. Kidney cancer mortality fifty-year latency patterns related to arsenic exposure. Epidemiology. 21:103-108.
152. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, Liaw J, Bates MN, Smith AH. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am J Epidemiol. 166:1381-1391.
153. Zhang C, Mao G, He S, Yang Z, Yang W, Zhang X, Qiu W, Ta N, Cao L, Yang H. 2013. Relationship between long-term exposure to low-level arsenic in drinking water and the prevalence of abnormal blood pressure. J Hazard Mater. 262:1154-1158.
154. Zhang L, Chen C. 1997. Geographic distribution and exposure population of drinking water with high concentration of arsenic in China. J Hyg Res. 26:310-313.